Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism (2019)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.3390/molecules24010143
- Subjects: ELÉTRONS; METABOLISMO; TOXINAS
- Keywords: Phenylbutazone; DFT; Electron transfer; Metabolism; Toxicity
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BORGES, Rosivaldo S. et al. Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism. Molecules, v. 24, n. 1, p. [16] , 2019Tradução . . Disponível em: https://doi.org/10.3390/molecules24010143. Acesso em: 27 abr. 2024. -
APA
Borges, R. S., Palheta, I. C., Ota, S. S. B., Morais, R. B., Barros, V. A., Ramos, R. S., et al. (2019). Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism. Molecules, 24( 1), [16] . doi:10.3390/molecules24010143 -
NLM
Borges RS, Palheta IC, Ota SSB, Morais RB, Barros VA, Ramos RS, Silva RC, Costa J da S, Silva CHT de P da, Campos JM, Santos CBR. Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism [Internet]. Molecules. 2019 ; 24( 1): [16] .[citado 2024 abr. 27 ] Available from: https://doi.org/10.3390/molecules24010143 -
Vancouver
Borges RS, Palheta IC, Ota SSB, Morais RB, Barros VA, Ramos RS, Silva RC, Costa J da S, Silva CHT de P da, Campos JM, Santos CBR. Toward of safer phenylbutazone derivatives by exploration of toxicity mechanism [Internet]. Molecules. 2019 ; 24( 1): [16] .[citado 2024 abr. 27 ] Available from: https://doi.org/10.3390/molecules24010143 - Química computacional no planejamento de candidatos a quimioterápicos
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
Informações sobre o DOI: 10.3390/molecules24010143 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002970527.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
